nodes	percent_of_prediction	percent_of_DWPC	metapath
Tenoxicam—CYP2C9—Teniposide—lymphatic system cancer	0.141	0.523	CbGbCtD
Tenoxicam—SLC22A8—Methotrexate—lymphatic system cancer	0.129	0.477	CbGbCtD
Tenoxicam—Gastrointestinal ulcer—Methotrexate—lymphatic system cancer	0.0231	0.0317	CcSEcCtD
Tenoxicam—Sleep disorder—Fludarabine—lymphatic system cancer	0.0101	0.0139	CcSEcCtD
Tenoxicam—Agranulocytosis—Mechlorethamine—lymphatic system cancer	0.00972	0.0133	CcSEcCtD
Tenoxicam—Visual disturbance—Fludarabine—lymphatic system cancer	0.00924	0.0127	CcSEcCtD
Tenoxicam—Cardiac failure—Fludarabine—lymphatic system cancer	0.00897	0.0123	CcSEcCtD
Tenoxicam—Erythema multiforme—Mechlorethamine—lymphatic system cancer	0.00884	0.0121	CcSEcCtD
Tenoxicam—Gastrointestinal haemorrhage—Fludarabine—lymphatic system cancer	0.00875	0.012	CcSEcCtD
Tenoxicam—Toxic epidermal necrolysis—Fludarabine—lymphatic system cancer	0.00788	0.0108	CcSEcCtD
Tenoxicam—Stomatitis—Teniposide—lymphatic system cancer	0.00748	0.0103	CcSEcCtD
Tenoxicam—Vertigo—Mechlorethamine—lymphatic system cancer	0.00731	0.01	CcSEcCtD
Tenoxicam—Leukopenia—Mechlorethamine—lymphatic system cancer	0.00728	0.00998	CcSEcCtD
Tenoxicam—Unspecified disorder of skin and subcutaneous tissue—Mechlorethamine—lymphatic system cancer	0.00688	0.00943	CcSEcCtD
Tenoxicam—Stevens-Johnson syndrome—Fludarabine—lymphatic system cancer	0.00669	0.00916	CcSEcCtD
Tenoxicam—Acute coronary syndrome—Fludarabine—lymphatic system cancer	0.00665	0.00911	CcSEcCtD
Tenoxicam—Anaphylactic shock—Mechlorethamine—lymphatic system cancer	0.00664	0.0091	CcSEcCtD
Tenoxicam—Myocardial infarction—Fludarabine—lymphatic system cancer	0.00661	0.00906	CcSEcCtD
Tenoxicam—Stomatitis—Fludarabine—lymphatic system cancer	0.00657	0.00901	CcSEcCtD
Tenoxicam—Thrombocytopenia—Mechlorethamine—lymphatic system cancer	0.0065	0.00891	CcSEcCtD
Tenoxicam—Skin disorder—Mechlorethamine—lymphatic system cancer	0.00645	0.00884	CcSEcCtD
Tenoxicam—Anorexia—Mechlorethamine—lymphatic system cancer	0.00633	0.00867	CcSEcCtD
Tenoxicam—Visual impairment—Fludarabine—lymphatic system cancer	0.00584	0.008	CcSEcCtD
Tenoxicam—Decreased appetite—Mechlorethamine—lymphatic system cancer	0.00577	0.00791	CcSEcCtD
Tenoxicam—Erythema multiforme—Fludarabine—lymphatic system cancer	0.00573	0.00785	CcSEcCtD
Tenoxicam—Gastrointestinal haemorrhage—Carmustine—lymphatic system cancer	0.0056	0.00768	CcSEcCtD
Tenoxicam—Anaemia—Teniposide—lymphatic system cancer	0.00554	0.0076	CcSEcCtD
Tenoxicam—Leukopenia—Teniposide—lymphatic system cancer	0.00537	0.00736	CcSEcCtD
Tenoxicam—Cardiac failure—Mitoxantrone—lymphatic system cancer	0.00534	0.00731	CcSEcCtD
Tenoxicam—Malnutrition—Fludarabine—lymphatic system cancer	0.00527	0.00722	CcSEcCtD
Tenoxicam—Gastrointestinal haemorrhage—Mitoxantrone—lymphatic system cancer	0.00521	0.00714	CcSEcCtD
Tenoxicam—Haematemesis—Methotrexate—lymphatic system cancer	0.00515	0.00705	CcSEcCtD
Tenoxicam—Oedema—Teniposide—lymphatic system cancer	0.00489	0.00671	CcSEcCtD
Tenoxicam—Hypersensitivity—Mechlorethamine—lymphatic system cancer	0.00489	0.0067	CcSEcCtD
Tenoxicam—Acute coronary syndrome—Bleomycin—lymphatic system cancer	0.00488	0.00668	CcSEcCtD
Tenoxicam—Anaemia—Fludarabine—lymphatic system cancer	0.00487	0.00668	CcSEcCtD
Tenoxicam—Myocardial infarction—Bleomycin—lymphatic system cancer	0.00485	0.00664	CcSEcCtD
Tenoxicam—Stomatitis—Bleomycin—lymphatic system cancer	0.00482	0.00661	CcSEcCtD
Tenoxicam—Thrombocytopenia—Teniposide—lymphatic system cancer	0.00479	0.00657	CcSEcCtD
Tenoxicam—Leukopenia—Fludarabine—lymphatic system cancer	0.00472	0.00647	CcSEcCtD
Tenoxicam—Pruritus—Mechlorethamine—lymphatic system cancer	0.0047	0.00644	CcSEcCtD
Tenoxicam—Anorexia—Teniposide—lymphatic system cancer	0.00467	0.00639	CcSEcCtD
Tenoxicam—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.00454	0.00622	CcSEcCtD
Tenoxicam—Dyspnoea—Teniposide—lymphatic system cancer	0.00436	0.00598	CcSEcCtD
Tenoxicam—Anaphylactic shock—Fludarabine—lymphatic system cancer	0.0043	0.00589	CcSEcCtD
Tenoxicam—Oedema—Fludarabine—lymphatic system cancer	0.0043	0.00589	CcSEcCtD
Tenoxicam—Decreased appetite—Teniposide—lymphatic system cancer	0.00426	0.00583	CcSEcCtD
Tenoxicam—Vomiting—Mechlorethamine—lymphatic system cancer	0.00422	0.00578	CcSEcCtD
Tenoxicam—Nervous system disorder—Fludarabine—lymphatic system cancer	0.00422	0.00578	CcSEcCtD
Tenoxicam—Photosensitivity reaction—Vincristine—lymphatic system cancer	0.00422	0.00578	CcSEcCtD
Tenoxicam—Thrombocytopenia—Fludarabine—lymphatic system cancer	0.00421	0.00577	CcSEcCtD
Tenoxicam—Stomatitis—Carmustine—lymphatic system cancer	0.00421	0.00577	CcSEcCtD
Tenoxicam—Rash—Mechlorethamine—lymphatic system cancer	0.00419	0.00574	CcSEcCtD
Tenoxicam—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00418	0.00573	CcSEcCtD
Tenoxicam—Anorexia—Fludarabine—lymphatic system cancer	0.0041	0.00562	CcSEcCtD
Tenoxicam—Acute coronary syndrome—Vincristine—lymphatic system cancer	0.00406	0.00557	CcSEcCtD
Tenoxicam—Myocardial infarction—Vincristine—lymphatic system cancer	0.00404	0.00554	CcSEcCtD
Tenoxicam—Stomatitis—Vincristine—lymphatic system cancer	0.00402	0.0055	CcSEcCtD
Tenoxicam—Acute coronary syndrome—Mitoxantrone—lymphatic system cancer	0.00396	0.00542	CcSEcCtD
Tenoxicam—Nausea—Mechlorethamine—lymphatic system cancer	0.00394	0.0054	CcSEcCtD
Tenoxicam—Myocardial infarction—Mitoxantrone—lymphatic system cancer	0.00393	0.00539	CcSEcCtD
Tenoxicam—Stomatitis—Mitoxantrone—lymphatic system cancer	0.00391	0.00536	CcSEcCtD
Tenoxicam—Urticaria—Teniposide—lymphatic system cancer	0.00389	0.00533	CcSEcCtD
Tenoxicam—Erythema—Bleomycin—lymphatic system cancer	0.00386	0.0053	CcSEcCtD
Tenoxicam—Dyspnoea—Fludarabine—lymphatic system cancer	0.00384	0.00526	CcSEcCtD
Tenoxicam—Dyspepsia—Fludarabine—lymphatic system cancer	0.00379	0.00519	CcSEcCtD
Tenoxicam—Agranulocytosis—Mitoxantrone—lymphatic system cancer	0.00375	0.00513	CcSEcCtD
Tenoxicam—Decreased appetite—Fludarabine—lymphatic system cancer	0.00374	0.00512	CcSEcCtD
Tenoxicam—Visual impairment—Carmustine—lymphatic system cancer	0.00373	0.00512	CcSEcCtD
Tenoxicam—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.00371	0.00509	CcSEcCtD
Tenoxicam—Fatigue—Fludarabine—lymphatic system cancer	0.00371	0.00508	CcSEcCtD
Tenoxicam—Constipation—Fludarabine—lymphatic system cancer	0.00368	0.00504	CcSEcCtD
Tenoxicam—Urinary tract disorder—Vincristine—lymphatic system cancer	0.00365	0.00501	CcSEcCtD
Tenoxicam—Urethral disorder—Vincristine—lymphatic system cancer	0.00363	0.00497	CcSEcCtD
Tenoxicam—Eye disorder—Carmustine—lymphatic system cancer	0.00362	0.00496	CcSEcCtD
Tenoxicam—Hypersensitivity—Teniposide—lymphatic system cancer	0.00361	0.00494	CcSEcCtD
Tenoxicam—Hepatitis—Mitoxantrone—lymphatic system cancer	0.0036	0.00494	CcSEcCtD
Tenoxicam—Anaemia—Bleomycin—lymphatic system cancer	0.00357	0.00489	CcSEcCtD
Tenoxicam—Asthenia—Teniposide—lymphatic system cancer	0.00351	0.00481	CcSEcCtD
Tenoxicam—Melaena—Methotrexate—lymphatic system cancer	0.00349	0.00478	CcSEcCtD
Tenoxicam—Pruritus—Teniposide—lymphatic system cancer	0.00346	0.00475	CcSEcCtD
Tenoxicam—Leukopenia—Bleomycin—lymphatic system cancer	0.00346	0.00474	CcSEcCtD
Tenoxicam—Cardiac disorder—Vincristine—lymphatic system cancer	0.00343	0.0047	CcSEcCtD
Tenoxicam—Mental disorder—Carmustine—lymphatic system cancer	0.0034	0.00465	CcSEcCtD
Tenoxicam—Erythema—Carmustine—lymphatic system cancer	0.00337	0.00462	CcSEcCtD
Tenoxicam—Malnutrition—Carmustine—lymphatic system cancer	0.00337	0.00462	CcSEcCtD
Tenoxicam—Angiopathy—Vincristine—lymphatic system cancer	0.00336	0.0046	CcSEcCtD
Tenoxicam—Diarrhoea—Teniposide—lymphatic system cancer	0.00335	0.00459	CcSEcCtD
Tenoxicam—Mental disorder—Vincristine—lymphatic system cancer	0.00324	0.00444	CcSEcCtD
Tenoxicam—Hypersensitivity—Fludarabine—lymphatic system cancer	0.00317	0.00434	CcSEcCtD
Tenoxicam—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.00315	0.00432	CcSEcCtD
Tenoxicam—Oedema—Bleomycin—lymphatic system cancer	0.00315	0.00432	CcSEcCtD
Tenoxicam—Erythema—Mitoxantrone—lymphatic system cancer	0.00314	0.0043	CcSEcCtD
Tenoxicam—Anaemia—Carmustine—lymphatic system cancer	0.00312	0.00427	CcSEcCtD
Tenoxicam—Vomiting—Teniposide—lymphatic system cancer	0.00311	0.00426	CcSEcCtD
Tenoxicam—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.00309	0.00423	CcSEcCtD
Tenoxicam—Asthenia—Fludarabine—lymphatic system cancer	0.00309	0.00423	CcSEcCtD
Tenoxicam—Rash—Teniposide—lymphatic system cancer	0.00309	0.00423	CcSEcCtD
Tenoxicam—Dermatitis—Teniposide—lymphatic system cancer	0.00308	0.00423	CcSEcCtD
Tenoxicam—Headache—Teniposide—lymphatic system cancer	0.00307	0.0042	CcSEcCtD
Tenoxicam—Pruritus—Fludarabine—lymphatic system cancer	0.00304	0.00417	CcSEcCtD
Tenoxicam—Leukopenia—Carmustine—lymphatic system cancer	0.00302	0.00414	CcSEcCtD
Tenoxicam—Anorexia—Bleomycin—lymphatic system cancer	0.00301	0.00412	CcSEcCtD
Tenoxicam—Anaemia—Vincristine—lymphatic system cancer	0.00298	0.00408	CcSEcCtD
Tenoxicam—Diarrhoea—Fludarabine—lymphatic system cancer	0.00294	0.00403	CcSEcCtD
Tenoxicam—Nausea—Teniposide—lymphatic system cancer	0.00291	0.00398	CcSEcCtD
Tenoxicam—Anaemia—Mitoxantrone—lymphatic system cancer	0.0029	0.00397	CcSEcCtD
Tenoxicam—Vertigo—Vincristine—lymphatic system cancer	0.00289	0.00396	CcSEcCtD
Tenoxicam—Leukopenia—Vincristine—lymphatic system cancer	0.00288	0.00395	CcSEcCtD
Tenoxicam—Dyspnoea—Bleomycin—lymphatic system cancer	0.00281	0.00385	CcSEcCtD
Tenoxicam—Leukopenia—Mitoxantrone—lymphatic system cancer	0.00281	0.00385	CcSEcCtD
Tenoxicam—Oedema—Carmustine—lymphatic system cancer	0.00275	0.00377	CcSEcCtD
Tenoxicam—Decreased appetite—Bleomycin—lymphatic system cancer	0.00274	0.00376	CcSEcCtD
Tenoxicam—Visual disturbance—Methotrexate—lymphatic system cancer	0.00274	0.00375	CcSEcCtD
Tenoxicam—Vomiting—Fludarabine—lymphatic system cancer	0.00274	0.00375	CcSEcCtD
Tenoxicam—Rash—Fludarabine—lymphatic system cancer	0.00271	0.00372	CcSEcCtD
Tenoxicam—Dermatitis—Fludarabine—lymphatic system cancer	0.00271	0.00371	CcSEcCtD
Tenoxicam—Thrombocytopenia—Carmustine—lymphatic system cancer	0.0027	0.00369	CcSEcCtD
Tenoxicam—Headache—Fludarabine—lymphatic system cancer	0.0027	0.00369	CcSEcCtD
Tenoxicam—Oedema—Vincristine—lymphatic system cancer	0.00263	0.0036	CcSEcCtD
Tenoxicam—Anaphylactic shock—Vincristine—lymphatic system cancer	0.00263	0.0036	CcSEcCtD
Tenoxicam—Anorexia—Carmustine—lymphatic system cancer	0.00262	0.0036	CcSEcCtD
Tenoxicam—Nervous system disorder—Vincristine—lymphatic system cancer	0.00258	0.00353	CcSEcCtD
Tenoxicam—Thrombocytopenia—Vincristine—lymphatic system cancer	0.00257	0.00353	CcSEcCtD
Tenoxicam—Oedema—Mitoxantrone—lymphatic system cancer	0.00256	0.00351	CcSEcCtD
Tenoxicam—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.00256	0.00351	CcSEcCtD
Tenoxicam—Nausea—Fludarabine—lymphatic system cancer	0.00256	0.0035	CcSEcCtD
Tenoxicam—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.00251	0.00343	CcSEcCtD
Tenoxicam—Urticaria—Bleomycin—lymphatic system cancer	0.00251	0.00343	CcSEcCtD
Tenoxicam—Anorexia—Vincristine—lymphatic system cancer	0.00251	0.00343	CcSEcCtD
Tenoxicam—Skin disorder—Mitoxantrone—lymphatic system cancer	0.00249	0.00341	CcSEcCtD
Tenoxicam—Dyspnoea—Carmustine—lymphatic system cancer	0.00245	0.00336	CcSEcCtD
Tenoxicam—Anorexia—Mitoxantrone—lymphatic system cancer	0.00244	0.00334	CcSEcCtD
Tenoxicam—Decreased appetite—Carmustine—lymphatic system cancer	0.00239	0.00328	CcSEcCtD
Tenoxicam—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.00238	0.00326	CcSEcCtD
Tenoxicam—Constipation—Carmustine—lymphatic system cancer	0.00235	0.00323	CcSEcCtD
Tenoxicam—Breast disorder—Methotrexate—lymphatic system cancer	0.00234	0.00321	CcSEcCtD
Tenoxicam—Toxic epidermal necrolysis—Methotrexate—lymphatic system cancer	0.00234	0.0032	CcSEcCtD
Tenoxicam—Hypersensitivity—Bleomycin—lymphatic system cancer	0.00232	0.00318	CcSEcCtD
Tenoxicam—Decreased appetite—Vincristine—lymphatic system cancer	0.00228	0.00313	CcSEcCtD
Tenoxicam—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.00228	0.00313	CcSEcCtD
Tenoxicam—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.00227	0.00311	CcSEcCtD
Tenoxicam—Fatigue—Vincristine—lymphatic system cancer	0.00227	0.00311	CcSEcCtD
Tenoxicam—Asthenia—Bleomycin—lymphatic system cancer	0.00226	0.0031	CcSEcCtD
Tenoxicam—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.00225	0.00309	CcSEcCtD
Tenoxicam—Constipation—Vincristine—lymphatic system cancer	0.00225	0.00308	CcSEcCtD
Tenoxicam—Asthma—Methotrexate—lymphatic system cancer	0.00224	0.00307	CcSEcCtD
Tenoxicam—Pruritus—Bleomycin—lymphatic system cancer	0.00223	0.00306	CcSEcCtD
Tenoxicam—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.00223	0.00305	CcSEcCtD
Tenoxicam—Fatigue—Mitoxantrone—lymphatic system cancer	0.00221	0.00302	CcSEcCtD
Tenoxicam—Constipation—Mitoxantrone—lymphatic system cancer	0.00219	0.003	CcSEcCtD
Tenoxicam—Abdominal discomfort—Methotrexate—lymphatic system cancer	0.00215	0.00295	CcSEcCtD
Tenoxicam—Photosensitivity reaction—Methotrexate—lymphatic system cancer	0.00205	0.0028	CcSEcCtD
Tenoxicam—Urticaria—Mitoxantrone—lymphatic system cancer	0.00203	0.00279	CcSEcCtD
Tenoxicam—Hypersensitivity—Carmustine—lymphatic system cancer	0.00203	0.00278	CcSEcCtD
Tenoxicam—Vomiting—Bleomycin—lymphatic system cancer	0.00201	0.00275	CcSEcCtD
Tenoxicam—Rash—Bleomycin—lymphatic system cancer	0.00199	0.00273	CcSEcCtD
Tenoxicam—Dermatitis—Bleomycin—lymphatic system cancer	0.00199	0.00272	CcSEcCtD
Tenoxicam—Stevens-Johnson syndrome—Methotrexate—lymphatic system cancer	0.00198	0.00272	CcSEcCtD
Tenoxicam—Asthenia—Carmustine—lymphatic system cancer	0.00198	0.00271	CcSEcCtD
Tenoxicam—Stomatitis—Methotrexate—lymphatic system cancer	0.00195	0.00267	CcSEcCtD
Tenoxicam—Hypersensitivity—Vincristine—lymphatic system cancer	0.00194	0.00265	CcSEcCtD
Tenoxicam—Hepatobiliary disease—Methotrexate—lymphatic system cancer	0.00189	0.00259	CcSEcCtD
Tenoxicam—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.00189	0.00258	CcSEcCtD
Tenoxicam—Asthenia—Vincristine—lymphatic system cancer	0.00189	0.00258	CcSEcCtD
Tenoxicam—Diarrhoea—Carmustine—lymphatic system cancer	0.00188	0.00258	CcSEcCtD
Tenoxicam—Nausea—Bleomycin—lymphatic system cancer	0.00187	0.00257	CcSEcCtD
Tenoxicam—Agranulocytosis—Methotrexate—lymphatic system cancer	0.00187	0.00256	CcSEcCtD
Tenoxicam—Asthenia—Mitoxantrone—lymphatic system cancer	0.00184	0.00252	CcSEcCtD
Tenoxicam—Dizziness—Carmustine—lymphatic system cancer	0.00182	0.00249	CcSEcCtD
Tenoxicam—Diarrhoea—Vincristine—lymphatic system cancer	0.0018	0.00246	CcSEcCtD
Tenoxicam—Hepatitis—Methotrexate—lymphatic system cancer	0.0018	0.00246	CcSEcCtD
Tenoxicam—Urinary tract disorder—Methotrexate—lymphatic system cancer	0.00177	0.00243	CcSEcCtD
Tenoxicam—Urethral disorder—Methotrexate—lymphatic system cancer	0.00176	0.00241	CcSEcCtD
Tenoxicam—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.00175	0.0024	CcSEcCtD
Tenoxicam—Vomiting—Carmustine—lymphatic system cancer	0.00175	0.0024	CcSEcCtD
Tenoxicam—Dizziness—Vincristine—lymphatic system cancer	0.00174	0.00238	CcSEcCtD
Tenoxicam—Rash—Carmustine—lymphatic system cancer	0.00174	0.00238	CcSEcCtD
Tenoxicam—Dermatitis—Carmustine—lymphatic system cancer	0.00173	0.00238	CcSEcCtD
Tenoxicam—Visual impairment—Methotrexate—lymphatic system cancer	0.00173	0.00237	CcSEcCtD
Tenoxicam—Headache—Carmustine—lymphatic system cancer	0.00172	0.00236	CcSEcCtD
Tenoxicam—Erythema multiforme—Methotrexate—lymphatic system cancer	0.0017	0.00233	CcSEcCtD
Tenoxicam—Eye disorder—Methotrexate—lymphatic system cancer	0.00168	0.0023	CcSEcCtD
Tenoxicam—Vomiting—Vincristine—lymphatic system cancer	0.00167	0.00229	CcSEcCtD
Tenoxicam—Cardiac disorder—Methotrexate—lymphatic system cancer	0.00167	0.00228	CcSEcCtD
Tenoxicam—Rash—Vincristine—lymphatic system cancer	0.00166	0.00227	CcSEcCtD
Tenoxicam—Dermatitis—Vincristine—lymphatic system cancer	0.00166	0.00227	CcSEcCtD
Tenoxicam—Headache—Vincristine—lymphatic system cancer	0.00165	0.00226	CcSEcCtD
Tenoxicam—Nausea—Carmustine—lymphatic system cancer	0.00164	0.00224	CcSEcCtD
Tenoxicam—Angiopathy—Methotrexate—lymphatic system cancer	0.00163	0.00223	CcSEcCtD
Tenoxicam—Vomiting—Mitoxantrone—lymphatic system cancer	0.00163	0.00223	CcSEcCtD
Tenoxicam—Immune system disorder—Methotrexate—lymphatic system cancer	0.00162	0.00222	CcSEcCtD
Tenoxicam—Rash—Mitoxantrone—lymphatic system cancer	0.00161	0.00221	CcSEcCtD
Tenoxicam—Dermatitis—Mitoxantrone—lymphatic system cancer	0.00161	0.00221	CcSEcCtD
Tenoxicam—Headache—Mitoxantrone—lymphatic system cancer	0.0016	0.0022	CcSEcCtD
Tenoxicam—Mental disorder—Methotrexate—lymphatic system cancer	0.00157	0.00215	CcSEcCtD
Tenoxicam—Erythema—Methotrexate—lymphatic system cancer	0.00156	0.00214	CcSEcCtD
Tenoxicam—Malnutrition—Methotrexate—lymphatic system cancer	0.00156	0.00214	CcSEcCtD
Tenoxicam—Nausea—Vincristine—lymphatic system cancer	0.00156	0.00214	CcSEcCtD
Tenoxicam—Nausea—Mitoxantrone—lymphatic system cancer	0.00152	0.00208	CcSEcCtD
Tenoxicam—Anaemia—Methotrexate—lymphatic system cancer	0.00144	0.00198	CcSEcCtD
Tenoxicam—Vertigo—Methotrexate—lymphatic system cancer	0.0014	0.00192	CcSEcCtD
Tenoxicam—Leukopenia—Methotrexate—lymphatic system cancer	0.0014	0.00192	CcSEcCtD
Tenoxicam—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.00132	0.00181	CcSEcCtD
Tenoxicam—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.00128	0.00175	CcSEcCtD
Tenoxicam—Nervous system disorder—Methotrexate—lymphatic system cancer	0.00125	0.00171	CcSEcCtD
Tenoxicam—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.00125	0.00171	CcSEcCtD
Tenoxicam—Skin disorder—Methotrexate—lymphatic system cancer	0.00124	0.0017	CcSEcCtD
Tenoxicam—Anorexia—Methotrexate—lymphatic system cancer	0.00122	0.00167	CcSEcCtD
Tenoxicam—Dyspnoea—Methotrexate—lymphatic system cancer	0.00114	0.00156	CcSEcCtD
Tenoxicam—Dyspepsia—Methotrexate—lymphatic system cancer	0.00112	0.00154	CcSEcCtD
Tenoxicam—Decreased appetite—Methotrexate—lymphatic system cancer	0.00111	0.00152	CcSEcCtD
Tenoxicam—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.0011	0.00151	CcSEcCtD
Tenoxicam—Fatigue—Methotrexate—lymphatic system cancer	0.0011	0.00151	CcSEcCtD
Tenoxicam—Urticaria—Methotrexate—lymphatic system cancer	0.00101	0.00139	CcSEcCtD
Tenoxicam—Hypersensitivity—Methotrexate—lymphatic system cancer	0.00094	0.00129	CcSEcCtD
Tenoxicam—Asthenia—Methotrexate—lymphatic system cancer	0.000915	0.00125	CcSEcCtD
Tenoxicam—Pruritus—Methotrexate—lymphatic system cancer	0.000902	0.00124	CcSEcCtD
Tenoxicam—Diarrhoea—Methotrexate—lymphatic system cancer	0.000873	0.0012	CcSEcCtD
Tenoxicam—Dizziness—Methotrexate—lymphatic system cancer	0.000843	0.00116	CcSEcCtD
Tenoxicam—Vomiting—Methotrexate—lymphatic system cancer	0.000811	0.00111	CcSEcCtD
Tenoxicam—Rash—Methotrexate—lymphatic system cancer	0.000804	0.0011	CcSEcCtD
Tenoxicam—Dermatitis—Methotrexate—lymphatic system cancer	0.000803	0.0011	CcSEcCtD
Tenoxicam—Headache—Methotrexate—lymphatic system cancer	0.000799	0.00109	CcSEcCtD
Tenoxicam—Nausea—Methotrexate—lymphatic system cancer	0.000758	0.00104	CcSEcCtD
